Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Total 13F shares
-
1,376,353
-
Share change
-
+39,288
-
Total reported value
-
$5,391,447
-
Put/Call ratio
-
14%
-
Price per share
-
$3.92
-
Number of holders
-
31
-
Value change
-
-$36,175
-
Number of buys
-
11
-
Number of sells
-
12
Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q1 2016
As of 31 Mar 2016,
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,376,353 shares.
The largest 10 holders included
VANGUARD GROUP INC, AMERICAN INTERNATIONAL GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, Skylands Capital, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BlackRock Fund Advisors, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Institutional Trust Company, N.A., and CREDIT SUISSE AG/.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.